Alamar Biosciences, Inc. — Investor Relations & Filings
Alamar Biosciences, Inc. is a commercial-stage proteomics company focused on powering precision proteomics for the earliest detection of disease. It develops and commercializes an automated, high-throughput, ultra-high sensitivity platform, including ARGO™ and NULISA™ technologies. This platform redefines protein biomarker detection by enabling the discovery of novel plasma biomarkers, even from low-volume specimens, that are often invisible with conventional immunoassays. The technology supports groundbreaking insights in biomarker discovery, drug development, and disease research, expanding applications across various conditions like Alzheimer's, TBI, and stroke, from pediatric to geriatric care.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q | 2026-05-08 | English | |
| 8-K | 2026-05-08 | English | |
| Major Shareholding Notification 2026 | 2026-04-23 | English | |
| Major Shareholding Notification 2026 | 2026-04-23 | English | |
| Regulatory Filings 2026 | 2026-04-21 | English | |
| S-8 | 2026-04-20 | English |
Browse filings by year
1 year| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46725313 | 10-Q | 2026-05-08 | English | ||
| 46725306 | 8-K | 2026-05-08 | English | ||
| 46725314 | Major Shareholding Notification 2026 | 2026-04-23 | English | ||
| 46725315 | Major Shareholding Notification 2026 | 2026-04-23 | English | ||
| 46725316 | Regulatory Filings 2026 | 2026-04-21 | English | ||
| 46725319 | S-8 | 2026-04-20 | English | ||
| 46725321 | 8-K | 2026-04-20 | English | ||
| 46725323 | POS AM | 2026-04-20 | English | ||
| 46725325 | 424B4 | 2026-04-17 | English | ||
| 46725326 | Regulatory Filings 2026 | 2026-04-17 | English | ||
| 46725329 | S-1MEF | 2026-04-17 | English | ||
| 46725328 | Regulatory Filings 2026 | 2026-04-16 | English | ||
| 46725327 | S-1/A | 2026-04-16 | English | ||
| 46725330 | 8-A12B | 2026-04-15 | English | ||
| 46725336 | S-1/A | 2026-04-13 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
CASSAVA SCIENCES INC
Clinical-stage biotech developing treatments for Central Ne…
|
SAVA | US | Professional, scientific and te… |
|
Celcuity Inc.
Clinical-stage biotech developing targeted therapies for mu…
|
CELC | US | Professional, scientific and te… |
|
Cell Bio Human Tech Co., Ltd
Develops and manufactures cellulose-based nonwoven fabrics …
|
318160 | KR | Professional, scientific and te… |
|
CEL SCI CORP
Clinical-stage biotech developing immunotherapies for cance…
|
CVM | US | Professional, scientific and te… |
|
Celyad Oncology SA
Biotechnology company developing innovative CAR-T cell ther…
|
CYAD | BE | Professional, scientific and te… |
|
Ceres Power Holdings PLC
A developer of solid oxide technology for clean power and g…
|
CWR | GB | Professional, scientific and te… |
|
Certara, Inc.
Accelerates drug development using biosimulation software, …
|
CERT | US | Professional, scientific and te… |
|
CervoMed Inc.
A clinical-stage biotech developing treatments for age-rela…
|
CRVO | US | Professional, scientific and te… |
|
Chabiotech Co.,Ltd.
Develops cell/gene therapies and provides CDMO and bio-bank…
|
085660 | KR | Professional, scientific and te… |
|
CHAMPIONS ONCOLOGY, INC.
A CRO providing end-to-end solutions to accelerate oncology…
|
CSBR | US | Professional, scientific and te… |
Alamar Biosciences, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/72612/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=72612 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=72612 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=72612 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 72612}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Alamar Biosciences, Inc. (id: 72612)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.